S. Deferme

925 total citations
16 papers, 703 citations indexed

About

S. Deferme is a scholar working on Oncology, Infectious Diseases and Pharmaceutical Science. According to data from OpenAlex, S. Deferme has authored 16 papers receiving a total of 703 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Infectious Diseases and 5 papers in Pharmaceutical Science. Recurrent topics in S. Deferme's work include Drug Transport and Resistance Mechanisms (9 papers), HIV/AIDS drug development and treatment (6 papers) and Drug Solubulity and Delivery Systems (5 papers). S. Deferme is often cited by papers focused on Drug Transport and Resistance Mechanisms (9 papers), HIV/AIDS drug development and treatment (6 papers) and Drug Solubulity and Delivery Systems (5 papers). S. Deferme collaborates with scholars based in Belgium, Germany and Tanzania. S. Deferme's co-authors include Patrick Augustijns, M. Oth, J. Van Gelder, Jan Tack, Frank Lammert, Guy Van den Mooter, Pieter Annaert, F. Ingels, Éric Destexhe and Jennifer Dressman and has published in prestigious journals such as International Journal of Pharmaceutics, Pharmaceutical Research and Journal of Pharmaceutical Sciences.

In The Last Decade

S. Deferme

16 papers receiving 684 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Deferme Belgium 13 298 297 119 118 117 16 703
Doo‐Man Oh United States 10 301 1.0× 188 0.6× 144 1.2× 68 0.6× 76 0.6× 13 645
J. Van Gelder Belgium 13 133 0.4× 144 0.5× 99 0.8× 73 0.6× 115 1.0× 15 444
Constantin Efthymiopoulos United Kingdom 12 138 0.5× 88 0.3× 96 0.8× 55 0.5× 59 0.5× 16 636
Marc Lindenberg Switzerland 7 491 1.6× 98 0.3× 122 1.0× 95 0.8× 44 0.4× 7 825
Araz Raoof Belgium 11 99 0.3× 77 0.3× 142 1.2× 63 0.5× 230 2.0× 22 608
Pradeep Sharma United Kingdom 20 172 0.6× 468 1.6× 201 1.7× 259 2.2× 94 0.8× 45 1.0k
Uwe Muenster Germany 14 650 2.2× 215 0.7× 157 1.3× 138 1.2× 39 0.3× 23 1.2k
Paulo Paixão Portugal 14 160 0.5× 100 0.3× 143 1.2× 61 0.5× 29 0.2× 34 608
Philip Sassene Denmark 16 850 2.9× 236 0.8× 183 1.5× 157 1.3× 18 0.2× 21 1.1k
Chung Y. Lui United States 11 134 0.4× 77 0.3× 63 0.5× 51 0.4× 26 0.2× 14 334

Countries citing papers authored by S. Deferme

Since Specialization
Citations

This map shows the geographic impact of S. Deferme's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Deferme with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Deferme more than expected).

Fields of papers citing papers by S. Deferme

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Deferme. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Deferme. The network helps show where S. Deferme may publish in the future.

Co-authorship network of co-authors of S. Deferme

This figure shows the co-authorship network connecting the top 25 collaborators of S. Deferme. A scholar is included among the top collaborators of S. Deferme based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Deferme. S. Deferme is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Deferme, S.. (2011). Automated blood sampling in drug discovery and development. 1 indexed citations
2.
Deferme, S., Pieter Annaert, & Patrick Augustijns. (2008). Drug Absorption Studies: In Situ, In Vitro and In Silico Models. 68 indexed citations
3.
Oth, M., S. Deferme, Frank Lammert, et al.. (2006). Characterization of fasted-state human intestinal fluids collected from duodenum and jejunum. Journal of Pharmacy and Pharmacology. 58(8). 1079–1089. 145 indexed citations
4.
Mols, Raf, S. Deferme, & Patrick Augustijns. (2005). Sulfasalazine transport in in-vitro, ex-vivo and in-vivo absorption models: contribution of efflux carriers and their modulation by co-administration of synthetic nature-identical fruit extracts. Journal of Pharmacy and Pharmacology. 57(12). 1565–1573. 26 indexed citations
5.
Deferme, S., et al.. (2003). Screening of Tanzanian plant extracts for their potential inhibitory effect on P‐glycoprotein mediated efflux. Phytotherapy Research. 17(5). 459–464. 12 indexed citations
6.
Deferme, S., Jan Tack, Frank Lammert, & Patrick Augustijns. (2003). P-Glycoprotein Attenuating Effect of Human Intestinal Fluid. Pharmaceutical Research. 20(6). 900–903. 31 indexed citations
7.
Ingels, F., et al.. (2003). Implementation of the caco-2 cell culture model as a predictive tool for the oral absorption of drugs. In-house evaluation procedures.. PubMed. 57(6). 153–8. 6 indexed citations
8.
Deferme, S. & Patrick Augustijns. (2003). The effect of food components on the absorption of P-gp substrates: a review. Journal of Pharmacy and Pharmacology. 55(2). 153–162. 56 indexed citations
9.
Gelder, J. Van, S. Deferme, Lieve Naesens, et al.. (2002). Intestinal Absorption Enhancement of the Ester Prodrug Tenofovir Disoproxil Fumarate through Modulation of the Biochemical Barrier by Defined Ester Mixtures. Drug Metabolism and Disposition. 30(8). 924–930. 81 indexed citations
10.
Ingels, F., S. Deferme, Éric Destexhe, et al.. (2002). Simulated intestinal fluid as transport medium in the Caco-2 cell culture model. International Journal of Pharmaceutics. 232(1-2). 183–192. 138 indexed citations
11.
Deferme, S., J. Van Gelder, F. Ingels, et al.. (2002). Intestinal absorption characteristics of the low solubility thiocarboxanilide UC-781. International Journal of Pharmaceutics. 234(1-2). 113–119. 21 indexed citations
12.
Deferme, S., Raf Mols, Willy Van Driessche, & Patrick Augustijns. (2002). Apricot Extract Inhibits the P-gp–Mediated Efflux of Talinolol. Journal of Pharmaceutical Sciences. 91(12). 2539–2548. 17 indexed citations
13.
Deferme, S., J. Van Gelder, & Patrick Augustijns. (2002). Inhibitory effect of fruit extracts on P-glycoproteinrelated efflux carriers: an in-vitro screening. Journal of Pharmacy and Pharmacology. 54(9). 1213–1219. 35 indexed citations
14.
Deferme, S., Gilles Gosselin, J.‐L. IMBACH, et al.. (2001). New bis(SATE) prodrug of AZT 5′‐monophosphate: In vitro anti‐HIV activity, stability, and potential oral absorption. Journal of Pharmaceutical Sciences. 90(4). 448–463. 27 indexed citations
15.
Gelder, J. Van, S. Deferme, Pieter Annaert, et al.. (2000). Increased Absorption of the Antiviral Ester Prodrug Tenofovir Disoproxil in Rat Ileum by Inhibiting Its Intestinal Metabolism. Drug Metabolism and Disposition. 28(12). 1394–1396. 36 indexed citations
16.
Gelder, J. Van, S. Deferme, Guy Van den Mooter, et al.. (2000). Increased oral absorption of the antiviral ester prodrug Tenofovir disoproxil in rat ileum. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026